Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here

Rhea-AI Summary

Ainos (NASDAQ:AIMD) has formed a strategic partnership with ugo Inc., a leading Japanese service robotics company, to integrate AI Nose technology into service robots. The collaboration, highlighted in a Water Tower Research report, marks a breakthrough in digitizing olfactory sensing.

The partnership aims to enhance robotic capabilities across industrial safety, public security, environmental monitoring, and healthcare. ugo, which leads Japan's service robot market share, deploys its robots in commercial buildings, data centers, factories, and public facilities.

The integration represents a significant advancement in robotics, adding smell capability to existing features like collision detection, AI-powered image recognition, and environmental sensing. Commercial deployment is expected by 2026, targeting the Japanese market, which accounts for 38% of worldwide robot production. The service robot market in Japan is projected to reach $1.2 billion by 2025, part of a $40.6 billion global market.

Positive

• Partnership with market leader ugo provides immediate access to commercial end-user market
• Targeting $40.6B global service robot market opportunity
• Integration into established, commercially viable robots already in use
• First-mover advantage in AI-powered smell sensing for robotics

Negative

• Commercial deployment not expected until 2026
• Revenue generation timeline uncertain
• Dependent on single partnership for market entry

Insights

Financial Analyst

Ainos' partnership with ugo represents a strategic market entry for its AI Nose technology, targeting the $40.6 billion global service robotics market. This collaboration is particularly significant as it provides immediate commercial viability through integration with an established market leader rather than an experimental startup.

The partnership creates multiple revenue streams across industrial safety, healthcare, security, and environmental monitoring sectors. Japan represents a strategic entry point as it accounts for 38% of global robot production. By focusing on the Japanese market first (projected at $1.2 billion by 2025), Ainos gains access to one of the world's most advanced robotics ecosystems.

What makes this partnership particularly valuable is ugo's existing commercial footprint in buildings, data centers, factories, and public facilities. Their robots already address Japan's workforce challenges from its aging population, creating natural market demand.

The timeline for revenue generation is clearly defined, with integration beginning in 2025 and commercial deployment by 2026. While this means near-term financial impact will be minimal, it establishes a clear path to monetization.

This partnership effectively transitions Ainos from a technology developer to a potential revenue-generating company with applications across multiple sectors. It validates their technology while providing a clear commercialization roadmap in a multi-billion dollar market.

Tech Industry Expert

Ainos' AI Nose technology represents a breakthrough in sensory AI by addressing the final frontier of robotic sensing. While vision, sound, and touch have seen tremendous advances in robotics, olfactory sensing has remained largely unexplored territory, giving Ainos a substantial first-mover advantage.

The practical applications are far-reaching. In industrial environments, smell detection can identify gas leaks, chemical spills or material degradation before they become dangerous. In healthcare, scent detection could potentially identify infections or disease markers. For security applications, detecting explosives, drugs or other contraband offers significant value.

ugo's robotic platform provides an ideal integration vehicle as it already features advanced AI capabilities including collision detection, image recognition, and environmental sensing. Adding olfactory sensing creates a more complete sensory package that directly addresses practical use cases.

What's particularly impressive about this partnership is its commercial readiness. Unlike many robotics innovations that remain in concept or prototype stage, ugo's robots are already deployed and commercially viable. This dramatically shortens the path to market for Ainos' technology.

The timing is perfect as Japan faces critical labor shortages due to its aging population, creating strong demand for service robots. With smell detection capabilities, these robots can perform enhanced monitoring and safety functions that previously required human intervention, addressing a genuine market need rather than being a technology looking for a problem.

i

Ainos' strategic partnership with ugo to integrate AI Nose technology into service robots represents a significant breakthrough in robotics. This collaboration brings olfactory sensing capabilities to robots, addressing the last frontier of sensory AI after vision, sound, and touch. The partnership targets multiple sectors including industrial safety, healthcare, and environmental monitoring, with integration beginning in 2025 and commercial deployment by 2026. Notably, this partnership provides Ainos immediate commercial viability through an established market leader rather than an experimental startup. ugo holds a leading position in Japan's service robotics market, with robots already deployed in commercial buildings, data centers, factories, and public facilities. Japan presents a strategic entry point as it accounts for 38% of global robot production, with its service robot market projected to reach $1.2 billion by 2025, within a global market of $40.6 billion. The collaboration addresses practical needs, particularly Japan's workforce challenges from its aging population, while creating multiple potential revenue streams across various industries. By combining ugo's established commercial footprint with Ainos' innovative AI Nose technology, this partnership positions Ainos to transition from technology developer to revenue-generating company, validating their technology with a clear commercialization roadmap in a substantial market.

a

Ainos' partnership with ugo represents a significant technological and commercial advancement in the robotics industry. This collaboration addresses the final frontier of robot sensing - smell - which has remained underdeveloped compared to vision, sound, and touch capabilities. The integration of AI Nose technology directly targets multiple high-value applications across industrial safety, healthcare, and environmental monitoring sectors. What makes this partnership particularly compelling is ugo's established market position in Japan's service robotics industry. Unlike many technology partnerships that pair with startups still in conceptual stages, ugo has commercially deployed robots in buildings, data centers, factories, and public facilities. This provides Ainos immediate access to end-user markets through an established distribution channel. The partnership's strategic value is amplified by Japan's demographics, where an aging population has created acute workforce shortages. Service robots addressing these gaps represent a $1.2 billion market opportunity by 2025 in Japan alone, within a $40.6 billion global market. With Japan accounting for 38% of worldwide robot production, this partnership positions Ainos at the center of robotics innovation. The defined timeline - integration beginning this year with commercial deployment by 2026 - establishes a clear path to revenue generation. This transforms Ainos from a technology developer to a company with multiple potential revenue streams across various sectors. The breakthrough nature of olfactory sensing in robotics positions Ainos with a first-mover advantage in a capability that completes the sensory package for advanced service robots. By addressing a genuine market need rather than being a technology seeking application, this partnership creates substantial long-term value potential for Ainos.

Practical partnership for AI Nose, multiple new opportunities

AI Nose to change robotics landscape with first AI smell sensing

SAN DIEGO, CA / ACCESS Newswire / March 7, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer of smell digitization, today announced that Water Tower Research ("WTR") has published a report on the Company's strategic partnership with ugo, Inc., a leading Japanese service robotics company. The collaboration will integrate Ainos' innovative AI Nose technology into ugo's service robots, marking a milestone in digitizing olfactory sensing.

Key Highlights from the Report:

• AI Nose Integration into Robots: This partnership will elevate robotic capabilities in industrial safety, public security, environmental monitoring, and healthcare. Both companies will jointly design AI Nose-enabled robots for various industries, open revenue opportunities in multiple sectors.

• This is a Practical Partnership: ugo develops and commercialized next-generation avatar robots and leads Japan's service robot market share. Its robots are used in commercial buildings, data centers, factories, and public facilities, addressing Japan's workforce shortage caused by aging population. Ainos' collaboration with an established player for autonomous robots provides direct commercial access to the end-user market, rather than with a startup still in the concept stage.

• Elevating Robot Functionality: ugo's robots are already equipped with advanced AI-driven features, such as collision detection sensors, AI-powered image recognition, and environmental sensors for heat mapping and humidity measurement. ugo's robots are practical and commercially viable, unlike many others that are still under development and remain costly.

• The Final Sense for Robots-AI Smell is Here: While vision, sound, and touch have seen significant advancements in robotics, the sense of smell has remained an untapped sensory capability. AI Nose represents a breakthrough in olfactory sensing, becoming one of the first technologies to offer robots the ability to smell. This new capability positions Ainos at the forefront of a rapidly evolving industry.

• Japan is a Key Market in a Multi-Billion Market Opportunity: Asia dominates the global robotics market, with China and Japan ranking among the top four for installed industrial robots, robotics innovation, and service robot production. Japan is a global leader in robotics, accounting for 38% of worldwide robot production in 2023. The service robot market in Japan is projected to reach $1.2 billion by 2025, compared to $9.7 billion in the U.S. and $40.6 billion globally.

• New Opportunities: Ainos' partnership with ugo unlocks significant opportunities across multiple sectors, including healthcare as well as industrial and public safety. The companies expect to begin integration this year, with commercial deployment anticipated as early as 2026. This partnership is poised to accelerate innovation in smart manufacturing and safety monitoring, with far-reaching implications for the robotics industry.

Link to the WTR report

About Ainos, Inc.
Headquartered in San Diego, California, Ainos, Inc. develops disruptive medical and healthcare solutions based on its proprietary AI Nose and VELDONA® technologies. The name "Ainos" combines "AI" and "Nose" to signify the Company's commitment to enabling AI with the ability to smell and individuals to live healthier. The Company's clinical-stage product pipeline includes AI-driven, telehealth-friendly POCT solutions powered by AI Nose, VELDONA® human and animal oral therapeutics, and human orphan drugs. To learn more, visit https://www.ainos.com. Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.

About ugo, Inc.
ugo, Inc. is a developer of business digital transformation robots. "ugo" is a next-generation avatar robot that realizes a sustainable work style with humans and robots. By combining the advantages of both conventional simple remote-controlled robots and fully automated robots, it provides operations that fit the site. ugo was founded in 2018 and headquartered in Tokyo, Japan. For more information, visit website https://ugo.plus or its X ( @ugo_robot ).

Forward-Looking Statements
Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which affect or may affect the Company's business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. There are a number of important factors that could cause actual results, developments, business decisions or other events to differ materially from those contemplated by the forward-looking statements in this press release. These factors include, among other things, our expectation that we will incur net losses for the foreseeable future; our ability to become profitable; our ability to raise additional capital to continue our product development; our ability to accurately predict our future operating results; our ability to advance our current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates we develop; the ability to obtain and maintain regulatory approval of our product candidates; delays in completing the development and commercialization of our current and future product candidates; developing and commercializing additional products, including diagnostic testing devices; our ability to compete in the marketplace; compliance with applicable laws, regulations and tariffs, and factors described in the Risk Factors section of our public filings with the Securities and Exchange Commission (SEC). Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this press release and, except to the extent required by applicable law, the Company undertakes no obligation to update or revise these statements, whether as a result of any new information, future events and developments or otherwise.

Contact Information
Feifei Shen
ir@ainos.com

SOURCE: Ainos, Inc.

View the original press release on ACCESS Newswire

FAQ

When will Ainos (AIMD) begin commercial deployment of AI Nose-enabled robots?

Commercial deployment of AIMD's AI Nose-enabled robots is anticipated to begin in 2026, following integration efforts starting in 2025.

What is the market size potential for AIMD's AI Nose technology in Japan?

Japan's service robot market is projected to reach $1.2 billion by 2025, with Japan accounting for 38% of worldwide robot production.

Which industries will AIMD's AI Nose technology target through the ugo partnership?

The technology will target industrial safety, public security, environmental monitoring, and healthcare sectors through ugo's existing robot deployment network.

How does AIMD's partnership with ugo advance robotics technology?

The partnership adds smell sensing capability to robots, complementing existing features like collision detection, AI image recognition, and environmental sensing.